HomeMAAT • EPA
add
Maat Pharma SA
Previous close
€7.60
Day range
€7.50 - €7.62
Year range
€6.30 - €9.90
Market cap
105.19M EUR
Avg Volume
1.33K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 860.50K | 24.89% |
Operating expense | 6.97M | 44.77% |
Net income | -6.43M | -52.41% |
Net profit margin | -747.01 | -22.04% |
Earnings per share | — | — |
EBITDA | -6.32M | -49.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.15M | -11.32% |
Total assets | 50.92M | 2.30% |
Total liabilities | 25.31M | 36.87% |
Total equity | 25.61M | — |
Shares outstanding | 13.92M | — |
Price to book | 4.13 | — |
Return on assets | -31.31% | — |
Return on capital | -37.27% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -6.43M | -52.41% |
Cash from operations | -6.30M | 3.58% |
Cash from investing | -29.50K | 80.13% |
Cash from financing | 9.77M | 47.88% |
Net change in cash | 3.44M | 4,340.74% |
Free cash flow | -3.33M | -23.00% |
About
Founded
2014
Website
Employees
54
